$ORMP

$4.08 -$0.05 (1.21%) Close

$ORMP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 41.6M shares outstanding

Who owns ORMP?

By type of holder

Institutions 40.3% Insiders 30.2% Everyone else 29.5%

Concentration Top 10 holders own 50.4%

Mercer Global Advisors Inc /adv 9.2% · BML Capital Management, LLC 2.1%

Institutional ownership

40.3%

+8.4 pts vs last qtr

Institutional holders

+19 vs last qtr

Net shares bought

+3.5M

by institutions in Q2 2026

New / sold out

29 / 10

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Mercer Global Advisors Inc /adv +1.9M
BlackRock, Inc. +1.5M

Biggest sellers in Q2 2026

BML Capital Management, LLC −2.3M
Marshall Wace, LLP −157.7K

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.34M

4 notices from 4 people

Shares covered

280.4K

0.67% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Hexter Joshua Officer 10b5-1 $659K
Gabay Avraham Officer 10b5-1 $449K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+8.8%

+2.84% a year

Each share's claim on the business

−8.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$7.23M vs $25.8M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years16% 3–5 years7% 1–3 years14% Under 1 year63%

Quarterly turnover

36.0%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting ORMP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MG Mercer Global Advisors Inc /adv	3.8M	9.16%	+1.9M (+99.4%)	Q1 '26	0.0%
Shares held by quarter Peak holding3.8M (Q2'26) Change over 8 quarters+3.8M Share of the company9.160% Mercer Global Advisors Inc /adv's full portfolio →
BC BML Capital Management, LLC	866.3K	2.08%	−2.3M (−72.6%)	2023	2.4%
Shares held by quarter Peak holding3.2M (Q3'25) Change over 8 quarters−1.3M Share of the company2.080% BML Capital Management, LLC's full portfolio →

Mercer Global Advisors Inc /adv

3.8M

% of company

9.16%

Change vs last qtr

+1.9M (+99.4%)

Held since

Q1 '26

BML Capital Management, LLC

866.3K

% of company

2.08%

Change vs last qtr

−2.3M (−72.6%)

Held since

2023

28 more super investors behind a free account

See every manager holding Oramed Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ORMP on Form N-PORT; together they hold 4.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IR iShares Russell 2000 ETF iShares Trust	$3.05M	634.6K	1.53%	0.00%	June 30, 2026
FS Fidelity Small Cap Index Fund Fidelity Salem Street Trust	$1.54M	378.5K	0.91%	0.00%	July 31, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$3.05M

% of company

1.53%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Small Cap Index Fund

Fidelity Salem Street Trust

Position value

$1.54M

% of company

0.91%

% of the fund

0.00%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding Oramed Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
NK Nadav Kidron 5%+ holder 13D · 7.6%	3.1M	7.49%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.490% Disclosed stake13D · 7.6% View the 13D/G filing →
SL Sank Leonard Insider	2.2M	5.19%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company5.190% Sank Leonard's insider activity →

Nadav Kidron

5%+ holder13D · 7.6%

3.1M

% of company

7.49%

Change vs last qtr

—

Held since

—

Sank Leonard

Insider

2.2M

% of company

5.19%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Oramed Pharmaceuticals Inc.

Comments